reports hero background
Updated: Nov 19, 2026
TTRX Logo

Turn Therapeutics

NASDAQ:TTRX·Stock Analysis Report
Day Range
$8.19 - $9.43
Market Cap
271.79M
P/E Ratio
0.0000
Avg Value
$9.13
Year Range
$2.70 - $15.56
$8.89$0.34 (3.98%)
1
General Information
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance.

The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

2
Turn Therapeutics (TTRX) Stock Graph
3
How We Grade Turn Therapeutics (TTRX)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade Turn Therapeutics (TTRX) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

Momentum measures a stock's relative strength based on its price movement patterns and volatility over multiple timeframes, ranked as a percentile against other stocks.

Stock Score Locked: Want to See it?
Benzinga Edge Rankings give you vital metrics on any stock – anytime.
5
Peer Ratings

See how Turn Therapeutics compares to its peers in these key performance metrics from Benzinga Rankings.

Top Peers
Value
Quality
Growth
Momentum
Short
Medium
Long
ACBAurora Cannabis
N/A
N/A
N/A
85.24
VFFVillage Farms Intl
N/A
N/A
8.79
N/A
FULCFulcrum Therapeutics
N/A
N/A
N/A
5.45
AGMBAgomAb Therapeutics
N/A
N/A
N/A
N/A
Short: price trend over the last couple of months
Medium: price trend over the last couple of quarters
Long: price trend over the past year
Stock Score Locked: Want to See it?
Benzinga Edge Rankings give you vital metrics on any stock – anytime.
6
Future Growth
Our estimate of future price growth is based on 1 analyst rating over the past 3 months and their 12-month price targets.

Below, you can see that analysts are estimating a 12-month price target range of $10.00 - $24.00 with an average of $14.67

64.98%
Expected movement for Turn Therapeutics (TTRX) over the next 12 months
Based on these rankings

Recent Ratings for Turn Therapeutics (TTRX)

WBB Securities
Date:
Oct 23, 2026
Action:
Upgrades
Prev. Target:
$10.00
New Target:
$10.00
7
Past Performance
How has Turn Therapeutics (TTRX) performed over the past 5 years?

The two main factors that we consider when analyzing past performance is overall return and volatility

Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.

This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.

Turn Therapeutics (TTRX) sharpe ratio over the past 5 years is 0.0788 which is considered to be above average compared to the peer average of -0.4706


Benzinga